Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum 09/16/2019 INTERVENTIONAL not-comparable 2,581.75 0 Improving Preschool Outcomes by Addressing Maternal Depression in Head Start 09/17/2019 INTERVENTIONAL not-comparable 2,580.75 0 A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer 09/17/2019 INTERVENTIONAL not-comparable 2,580.75 0 Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama 09/18/2019 INTERVENTIONAL not-comparable 2,579.75 0 Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy 09/19/2019 INTERVENTIONAL not-comparable 2,578.75 0 Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 09/19/2019 INTERVENTIONAL not-comparable 2,578.75 0 Alternative Prophylaxis in Female Recurrent Urinary Tract Infections 09/19/2019 INTERVENTIONAL not-comparable 2,578.75 0 Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) 09/23/2019 INTERVENTIONAL not-comparable 2,574.75 0 Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST 09/24/2019 INTERVENTIONAL not-comparable 2,573.75 0 Advancing Postmenopausal Preventive Therapy 09/25/2019 INTERVENTIONAL not-comparable 2,572.75 0 Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment 09/27/2019 INTERVENTIONAL not-comparable 2,570.75 0 Pilot Study for Speculum Free Cervical Cancer Screening 09/27/2019 INTERVENTIONAL not-comparable 2,570.75 0 Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa 09/27/2019 INTERVENTIONAL not-comparable 2,570.75 0 Obstetric Placement Study Using EST 09/30/2019 INTERVENTIONAL not-comparable 2,567.75 0 Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos 09/30/2019 INTERVENTIONAL not-comparable 2,567.75 0 Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs 10/01/2019 OBSERVATIONAL not-comparable 2,566.75 0 MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) 10/02/2019 INTERVENTIONAL not-comparable 2,565.75 0 Mitochondrial Donation: An 18 Month Outcome Study. 10/02/2019 OBSERVATIONAL not-comparable 2,565.75 0 Bazedoxifene -Treatment for Women With Schizophrenia 10/03/2019 INTERVENTIONAL not-comparable 2,564.75 0 Trial of Flexible Bracing Treatment of Adolescents Idiopathic Scoliosis 10/07/2019 INTERVENTIONAL not-comparable 2,560.75 0 NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer 10/08/2019 OBSERVATIONAL not-comparable 2,559.75 0 Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age 10/08/2019 OBSERVATIONAL not-comparable 2,559.75 0 Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women 10/11/2019 INTERVENTIONAL not-comparable 2,556.75 0 The SONImage Study 10/14/2019 INTERVENTIONAL not-comparable 2,553.75 0 Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer 10/15/2019 INTERVENTIONAL not-comparable 2,552.75 0 Effect of Addition of Steroids on Duration of Analgesia 10/15/2019 INTERVENTIONAL not-comparable 2,552.75 0 In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility 10/16/2019 INTERVENTIONAL not-comparable 2,551.75 0 Intraperitoneal Infusion of Analgesic for Postoperative Pain Management 10/17/2019 INTERVENTIONAL not-comparable 2,550.75 0 HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia 10/18/2019 INTERVENTIONAL not-comparable 2,549.75 0 Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer 10/21/2019 INTERVENTIONAL not-comparable 2,546.75 0 ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer 10/22/2019 INTERVENTIONAL not-comparable 2,545.75 0 Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer 10/22/2019 INTERVENTIONAL not-comparable 2,545.75 0 Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer 10/23/2019 INTERVENTIONAL not-comparable 2,544.75 0 Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT 10/24/2019 INTERVENTIONAL not-comparable 2,543.75 0 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer 10/24/2019 INTERVENTIONAL not-comparable 2,543.75 0 Autonomic Determinants of POTS - Pilot 2 10/28/2019 INTERVENTIONAL not-comparable 2,539.75 0 LUMIERE on the FETUS 10/29/2019 OBSERVATIONAL not-comparable 2,538.75 0 A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception 10/29/2019 INTERVENTIONAL not-comparable 2,538.75 0 A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ 10/30/2019 INTERVENTIONAL not-comparable 2,537.75 0 Von Willebrand Factor in Pregnancy (VIP) Study 10/31/2019 OBSERVATIONAL not-comparable 2,536.75 0 IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer 11/04/2019 INTERVENTIONAL not-comparable 2,532.75 0 Conservative Endometrioma Surgery 11/05/2019 INTERVENTIONAL not-comparable 2,531.75 0 Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer 11/05/2019 OBSERVATIONAL not-comparable 2,531.75 0 Exosome Cargo From Preeclampsia Patients 11/06/2019 OBSERVATIONAL not-comparable 2,530.75 0 Creation and Validation of a Questionnaire Evaluating Diastasis Recti 11/08/2019 OBSERVATIONAL not-comparable 2,528.75 0 Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer 11/08/2019 INTERVENTIONAL not-comparable 2,528.75 0 Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis 11/12/2019 INTERVENTIONAL not-comparable 2,524.75 0 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer 11/12/2019 INTERVENTIONAL not-comparable 2,524.75 0 Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy 11/13/2019 INTERVENTIONAL not-comparable 2,523.75 0 Trigger Timing in Ovarian Stimulations 11/14/2019 INTERVENTIONAL not-comparable 2,522.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology